Roxadustat and the Interpretation of Non-Inferiority
freecme000
Published on Nov 29, 2022
CLICK ON LINK BELOW
https://www.asn-online.org/media/podcast/JASN/2022_04_11_JASN2021050681.mp3
Dr. Josie Briggs, discusses a non-inferiority trial on Roxadustat in dialysis patients and explains the interpretation of the finding that roxadustat is non-inferior to epoetin alpha.
Category
Tags
- Your Subscription
freecme000 -
Share Podcast
Add to
Please Sign In or Create Account to use this feature!
Flag Podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
00:04
Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy
24 views 1129 days ago -
00:04
Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors
22 views 1129 days ago -
00:04
Addressing CKD Progression and Hazards of Intradialytic Hypotension
27 views 834 days ago